首页> 外文期刊>Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism >Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature.
【24h】

Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature.

机译:降钙素受体样受体和受体活性修饰蛋白在人脑血管中的免疫组织化学定位。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Calcitonin gene-related peptide and adrenomedullin belong to a structurally related neuropeptide family and are potent vasodilators expressed in the trigeminovascular system. The molecular identity of receptors for these proteins has only recently been elucidated. Central to functional binding of these neuropeptides is the G-protein-coupled receptor, the calcitonin receptor-like receptor (CRLR), whose cell surface expression and pharmacology is determined by coexpression of a receptor activity-modifying protein (RAMP). CRLR combined with RAMP binds calcitonin gene-related peptide with high affinity, whereas CRLR coexpression with RAMP2 or -3 confers high-affinity binding of adrenomedullin. The authors investigated the expression of these receptor components in human cerebral vasculature to further characterize neuropeptide receptor content and the potential functions of these receptors. Localization has been carried out using specific antisera raised against immunogenic peptide sequences that were subsequently applied using modern immunohistochemical techniques and confocal microscopy. The results are the first to show the presence of these receptor component proteins in human middle meningeal, middle cerebral, pial, and superficial temporal vessels, and confirm that both calcitonin gene-related peptide and adrenomedullin receptors may arise from the coassembly of RAMPs with CRLR in these vessel types. These novel data advance the understanding of the molecular function of the trigeminovascular system, its potential role in vascular headache disorders such as migraine, and may lead to possible ways in which future synthetic ligands may be applied to manage these disorders.
机译:降钙素基因相关肽和肾上腺髓质素属于结构相关的神经肽家族,并且是在三叉神经血管系统中表达的有效血管扩张剂。这些蛋白质的受体的分子同一性直到最近才被阐明。这些神经肽功能结合的核心是G蛋白偶联受体,降钙素受体样受体(CRLR),其细胞表面表达和药理作用是通过共表达受体活性修饰蛋白(RAMP)来确定的。 CRLR与RAMP结合以高亲和力结合降钙素基因相关肽,而CRLR与RAMP2或-3共表达赋予肾上腺髓质素高亲和力结合。作者研究了这些受体成分在人脑血管中的表达,以进一步表征神经肽受体的含量和这些受体的潜在功能。使用针对免疫原性肽序列的特异性抗血清进行了定位,随后使用现代免疫组织化学技术和共聚焦显微镜对其进行了应用。结果首次显示出这些受体成分蛋白存在于人类中脑膜,大脑中部,小脑和浅表颞叶血管中,并证实降钙素基因相关肽和肾上腺髓质素受体均可能是由R​​AMP与CRLR的共组装引起的在这些船只类型中。这些新颖的数据促进了对三叉神经血管系统分子功能及其在血管性头痛疾病(例如偏头痛)中的潜在作用的理解,并可能导致未来合成配体可用于治疗这些疾病的可能方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号